TORRENT PHARMACEUTICALS
|
TORRENT PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹16,321 Cr | ₹15,211 Cr | ₹14,878 Cr | ₹14,953 Cr | ₹14,527 Cr |
Sales | ₹16,164 Cr | ₹15,122 Cr | ₹14,760 Cr | ₹14,794 Cr | ₹14,316 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | - | - | - | - | - |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹156 Cr | ₹89 Cr | ₹118 Cr | ₹159 Cr | ₹211 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹9,620 Cr | ₹8,508 Cr | ₹8,005 Cr | ₹7,939 Cr | ₹7,673 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹166 Cr | ₹74 Cr | ₹-279 Cr | ₹-133 Cr | ₹83 Cr |
Raw Material Consumed | ₹2,347 Cr | ₹2,157 Cr | ₹2,239 Cr | ₹2,115 Cr | ₹1,958 Cr |
Opening Raw Materials | ₹841 Cr | ₹985 Cr | ₹741 Cr | ₹664 Cr | ₹604 Cr |
Purchases Raw Materials | ₹1,170 Cr | ₹1,182 Cr | ₹1,478 Cr | ₹1,270 Cr | ₹1,171 Cr |
Closing Raw Materials | ₹752 Cr | ₹841 Cr | ₹985 Cr | ₹741 Cr | ₹664 Cr |
Other Direct Purchases / Brought in cost | ₹1,089 Cr | ₹831 Cr | ₹1,005 Cr | ₹923 Cr | ₹846 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹155 Cr | ₹144 Cr | ₹123 Cr | ₹128 Cr | ₹132 Cr |
Electricity & Power | ₹155 Cr | ₹144 Cr | ₹123 Cr | ₹128 Cr | ₹132 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹1,678 Cr | ₹1,526 Cr | ₹1,440 Cr | ₹1,429 Cr | ₹1,404 Cr |
Salaries, Wages & Bonus | ₹1,433 Cr | ₹1,305 Cr | ₹1,245 Cr | ₹1,233 Cr | ₹1,208 Cr |
Contributions to EPF & Pension Funds | ₹153 Cr | ₹134 Cr | ₹118 Cr | ₹123 Cr | ₹124 Cr |
Workmen and Staff Welfare Expenses | ₹63 Cr | ₹60 Cr | ₹49 Cr | ₹51 Cr | ₹49 Cr |
Other Employees Cost | ₹29 Cr | ₹28 Cr | ₹26 Cr | ₹22 Cr | ₹22 Cr |
Other Manufacturing Expenses | ₹571 Cr | ₹591 Cr | ₹551 Cr | ₹544 Cr | ₹559 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | ₹84 Cr | ₹88 Cr | ₹75 Cr | ₹51 Cr | ₹58 Cr |
Repairs and Maintenance | - | - | - | - | - |
Packing Material Consumed | ₹222 Cr | ₹211 Cr | ₹186 Cr | ₹185 Cr | ₹178 Cr |
Other Mfg Exp | ₹265 Cr | ₹292 Cr | ₹290 Cr | ₹308 Cr | ₹322 Cr |
General and Administration Expenses | ₹775 Cr | ₹638 Cr | ₹633 Cr | ₹802 Cr | ₹764 Cr |
Rent , Rates & Taxes | - | - | - | - | - |
Insurance | - | - | - | - | - |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹137 Cr | ₹111 Cr | ₹140 Cr | ₹88 Cr | ₹137 Cr |
Traveling and conveyance | ₹158 Cr | ₹82 Cr | ₹62 Cr | ₹108 Cr | ₹129 Cr |
Other Administration | ₹480 Cr | ₹445 Cr | ₹432 Cr | ₹606 Cr | ₹498 Cr |
Selling and Distribution Expenses | ₹1,027 Cr | ₹885 Cr | ₹743 Cr | ₹807 Cr | ₹738 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | - | - | - | - | - |
Freight and Forwarding | - | - | - | - | - |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹1,027 Cr | ₹885 Cr | ₹743 Cr | ₹807 Cr | ₹738 Cr |
Miscellaneous Expenses | ₹77 Cr | ₹62 Cr | ₹75 Cr | ₹76 Cr | ₹58 Cr |
Bad debts /advances written off | - | - | - | - | - |
Provision for doubtful debts | ₹2.27 Cr | ₹0.90 Cr | ₹14 Cr | - | - |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | ₹18 Cr | - | - | - | ₹1.09 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹57 Cr | ₹61 Cr | ₹60 Cr | ₹76 Cr | ₹57 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹6,796 Cr | ₹6,077 Cr | ₹5,524 Cr | ₹5,769 Cr | ₹5,696 Cr |
Operating Profit (Excl OI) | ₹2,824 Cr | ₹2,431 Cr | ₹2,480 Cr | ₹2,170 Cr | ₹1,976 Cr |
Other Income | ₹63 Cr | ₹197 Cr | ₹57 Cr | ₹121 Cr | ₹64 Cr |
Interest Received | ₹15 Cr | ₹7.15 Cr | ₹5.07 Cr | ₹7.96 Cr | ₹16 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹22 Cr | - | - | - | - |
Profits on sale of Investments | ₹19 Cr | ₹9.88 Cr | ₹16 Cr | ₹29 Cr | ₹39 Cr |
Provision Written Back | - | - | - | - | ₹5.48 Cr |
Foreign Exchange Gains | - | ₹170 Cr | ₹32 Cr | ₹83 Cr | - |
Others | ₹7.45 Cr | ₹9.99 Cr | ₹4.37 Cr | ₹1.40 Cr | ₹2.46 Cr |
Operating Profit | ₹2,887 Cr | ₹2,628 Cr | ₹2,537 Cr | ₹2,292 Cr | ₹2,040 Cr |
Interest | ₹333 Cr | ₹255 Cr | ₹353 Cr | ₹451 Cr | ₹504 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹1.20 Cr | ₹2.13 Cr | ₹2.12 Cr | ₹2.35 Cr | ₹2.65 Cr |
Other Interest | ₹332 Cr | ₹253 Cr | ₹351 Cr | ₹448 Cr | ₹501 Cr |
PBDT | ₹2,554 Cr | ₹2,373 Cr | ₹2,184 Cr | ₹1,841 Cr | ₹1,536 Cr |
Depreciation | ₹707 Cr | ₹662 Cr | ₹658 Cr | ₹654 Cr | ₹618 Cr |
Profit Before Taxation & Exceptional Items | ₹1,847 Cr | ₹1,711 Cr | ₹1,526 Cr | ₹1,187 Cr | ₹919 Cr |
Exceptional Income / Expenses | - | ₹-485 Cr | - | - | ₹-357 Cr |
Profit Before Tax | ₹1,847 Cr | ₹1,226 Cr | ₹1,526 Cr | ₹1,187 Cr | ₹562 Cr |
Provision for Tax | ₹602 Cr | ₹449 Cr | ₹274 Cr | ₹162 Cr | ₹125 Cr |
Current Income Tax | ₹355 Cr | ₹346 Cr | ₹334 Cr | ₹260 Cr | ₹279 Cr |
Deferred Tax | ₹228 Cr | ₹107 Cr | ₹-53 Cr | ₹-59 Cr | ₹-155 Cr |
Other taxes | ₹20 Cr | ₹-4.02 Cr | ₹-6.72 Cr | ₹-39 Cr | ₹1.34 Cr |
Profit After Tax | ₹1,245 Cr | ₹777 Cr | ₹1,252 Cr | ₹1,025 Cr | ₹436 Cr |
Extra items | - | - | - | - | - |
Minority Interest | - | - | - | - | ₹-0.03 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹1,245 Cr | ₹777 Cr | ₹1,252 Cr | ₹1,025 Cr | ₹436 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹2,917 Cr | ₹2,806 Cr | ₹1,893 Cr | ₹1,616 Cr | ₹1,554 Cr |
Appropriations | ₹4,162 Cr | ₹3,584 Cr | ₹3,145 Cr | ₹2,641 Cr | ₹1,990 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | ₹125 Cr | ₹63 Cr |
Other Appropriation | ₹385 Cr | ₹244 Cr | ₹-0.04 Cr | ₹81 Cr | ₹91 Cr |
Equity Dividend % | ₹440.00 | ₹960.00 | ₹700.00 | ₹640.00 | ₹340.00 |
Earnings Per Share | ₹36.79 | ₹45.92 | ₹73.97 | ₹60.55 | ₹25.78 |
Adjusted EPS | ₹36.79 | ₹22.96 | ₹36.99 | ₹30.27 | ₹12.89 |
Compare Income Statement of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹115,201.5 Cr | -0.1% | 0.4% | 75.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹457,025.0 Cr | -2% | 4.3% | 65.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,952.0 Cr | -0.5% | 6.4% | 44.2% | Stock Analytics | |
CIPLA | ₹131,056.0 Cr | -2.9% | -1.8% | 39.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,731.0 Cr | -1.8% | -2.2% | 20.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,745.0 Cr | -1.6% | -6.3% | 73.8% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | -0.1% |
0.4% |
75.8% |
SENSEX | -5.3% |
-1.6% |
23.1% |
You may also like the below Video Courses